Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Issa

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countriesAnnie O Chan, Amr S Soliman, Qing Zhang, et al.
Cell Reports|February 21, 2019
Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder CarcinogenesisTadeusz Majewski, Hui Yao, Jolanta Bondaruk, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2007
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasiaSangkyou Lee, Joon Jeong, Tadeusz Majewski, et al.
Blood|July 3, 2009
Mutations in CBL occur frequently in juvenile myelomonocytic leukemiaMignon L Loh, Debbie S Sakai, Christian Flotho, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2015
New DNA methylation markers and global DNA hypomethylation are associated with oral cancer developmentJean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.
Cancer Cell|February 13, 2019
Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf<sup>V600E</sup>-Induced TumorigenesisYong Tao, Byunghak Kang, Daniel A Petkovich, et al.
International Journal of Cancer|August 25, 2017
Roadmap for investigating epigenome deregulation and environmental origins of cancerZdenko Herceg, Akram Ghantous, Christopher P Wild, et al.
Cancer Cell|March 24, 2012
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cellsHsing-Chen Tsai, Huili Li, Leander Van Neste, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
ZNFX1 is a Novel Master Regulator in Epigenetically-induced Pathogen Mimicry and Inflammasome Signaling in CancerLora Stojanovic, Rachel Abbotts, Kaushlendra Tripathi, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countriesAnnie O Chan, Amr S Soliman, Qing Zhang, et al.
Cell Reports|February 21, 2019
Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder CarcinogenesisTadeusz Majewski, Hui Yao, Jolanta Bondaruk, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2007
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasiaSangkyou Lee, Joon Jeong, Tadeusz Majewski, et al.
Blood|July 3, 2009
Mutations in CBL occur frequently in juvenile myelomonocytic leukemiaMignon L Loh, Debbie S Sakai, Christian Flotho, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2015
New DNA methylation markers and global DNA hypomethylation are associated with oral cancer developmentJean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.
Cancer Cell|February 13, 2019
Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf<sup>V600E</sup>-Induced TumorigenesisYong Tao, Byunghak Kang, Daniel A Petkovich, et al.
International Journal of Cancer|August 25, 2017
Roadmap for investigating epigenome deregulation and environmental origins of cancerZdenko Herceg, Akram Ghantous, Christopher P Wild, et al.
Cancer Cell|March 24, 2012
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cellsHsing-Chen Tsai, Huili Li, Leander Van Neste, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
ZNFX1 is a Novel Master Regulator in Epigenetically-induced Pathogen Mimicry and Inflammasome Signaling in CancerLora Stojanovic, Rachel Abbotts, Kaushlendra Tripathi, et al.
Pageof 10